Speakers

Jason Acker

Professor

University of Alberta, Canada

Brittany Adcock

Talent Acquisition Partner, HR Talent Strategy & Acquisition, Cell Therapy Development

Bristol Myers Squibb

Jennifer Adrian

Manager, Cellular Therapy Manufacturing Operations

bluebird bio

Regina Au

Principal

BioMarketing Insight

Sarah Auclair

Scientist

Sanofi

Jeffrey Baker

Deputy Director, Office of Biotechnology Products, CDER, FDA

CDER, FDA

Randal Bass, Ph.D.

Vice President of Process Design

Just - Evotec Biologics

Marc Bisschops, Ph.D.

Technology Director, Continuous Processing

Pall Life Sciences, Holland

Thomas Bollenbach

Chief Technology Officer

Advanced Regenerative Manufacturing Institute

Mike Brewer

Product Management Leader

Thermo Fisher Scientific

Kurt Brorson

Vice President, Technical

Parexel

Kurt Brorson, PhD

Vice President, Technical

Parexel International

Kristi Budzinski

Principal Product Stewardship Program Manager

Genentech

Scott Burger

Principal

Advanced Cell & Gene Therapy, USA

Michael Butler

Chief Scientific Officer (CSO)

National Institute of Bioprocessing Research & Training (NIBRT), Ireland

Veeren Chauhan

Nottingham Research Fellow in Bio-inspired Therapeutics in the Advanced Materials & Healthcare Technologies

University of Nottingham

Sabine Chlosta

Chief Medical Officer

Triumvira, USA

Kathryn Corzo

Head of Development Oncology Cell Therapies

Takeda Oncology

Lisa Deschamps

SVP, Chief Business Officer

Novartis Gene Therapies

Kimberly DiGiandomenico, MS, RBP

Senior Manager – Biological, Radiation & Laboratory Safety Biosafety Officer

AstraZeneca

Weibing Ding

Director

GSK

Brandon Downey

Principal Engineer, R&D

Lonza

Cameron Durrant

Chairman and CEO

Humanigen, Inc.

Allen Feng

Chief Scientific Officer

HebeCell Corp., USA

Tom Fletcher

Scientific Director

FUJIFILM Irvine Scientific

Jishna Ganguly

Associate Research Scientist

GSK

Chris Gemmiti

Vice President, Operations

Sentien Biotechnologies, Inc., USA

Christoph Herwig

Head Biochemical Engineering, Institute of Chemical Engineering

TU Wien, Austria

Sung Ho Hahm

CEO

Rophibio Inc.

Moo Sun Hong

Ph.D. candidate

MIT

Habib Horry

Associate Director of Marketing, Upstream Solutions

MilliporeSigma

Ellen Johnson

Enterprise Solutions Technology Leader

Cytiva

Jeff Johnson

President

Biotech Design, LLC

David Kahn, Ph.D.

Vice President of Biopharmaceutical Development

Macrogenics

Martijin J. E. Kelder, PhD

Strategic Account Manager

Cergentis

Saad Kenderian

Assistant Professor, Medicine, Oncology and Immunology, Director, T Cell Engineering

Mayo Clinic, USA

Jonathan Kingsbury

Head of Developability & Pre-formulation

Sanofi

Vadim Klyushnichenko

VP Pharmaceutical Development and Quality

Calibr at Scripps Research

Jak Knowles

VP Venture Investments

Bayer

Thomas R. Kreil

Vice President, Global Pathogen Safety

Takeda

Tae Kwang Ha

Specialist

Novo Nordisk Foundation Center for Biosustainability, DTU

Lucia Lapazio

R&D Biologics Development, Process Purification Development

Sanofi

Howard Levine, PhD

National Leader

BioProcess Technology Group

Sara Levy

CSV & Data integrity Manager

Pluristem Therapeutics Inc.

John Lewis

Co-Founder & CEO

Aegis BioDefense Inc., USA

Nathan Lewis, PhD

Assistant Professor, Department of Pediatrics

University of California, San Diego

Mengyao Li

Post Doc Next Generation High-Densit,Advanced Process & Manufacturing Technology

Novartis Pharma AG

Perri Lucatello

Cell & Gene Therapy Portfolio Sales Head

Informa

Joey Mason

Head of the Life Sciences Fund

M Ventures, The Netherlands

David McKenna

Professor and American Red Cross Chair in Transfusion Medicine, Department of Laboratory Medicine and Pathology

University of Minnesota

Anthony Mire-Sluis

Head of Global Quality

AstraZeneca

Shahram Misaghi, PhD

Senior Scientist

Genentech, Inc

Ali Mohamed

VP, CMC

Immatics, USA

Thomas Mueller-Spaeth, Ph.D

Director, R&D Life Science Systems

ChromaCon AG

Mustafa Munye

Lead Scientist

Cell and Gene Therapy Catapult

Benjamin Neunstoecklin, Ph.D.

Principal Scientist

Novartis

Sarah Nikiforow

Asst. Professor, Stem Cell Transplantation Program, Asst. Medical Director, Cell Manipulation Core Facility

Dana-Farber Cancer Institute

Nicole Nuñez, Ph.D.,

Process Development Scientist

Eureka Therapeutics, Inc.

Racheli Ofir

Vice President Research & Intellectual Property

Pluristem Therapeutics Inc., Israel

Steve Oh

Director Stem Cell Bioprocessing & Institute Professor,

A*Star, Singapore

Philippe Parone

Industrialisation Lead

Celyad, USA

Loren A Perelman, PhD

Vice President of Scientific Solutions

Riffyn

Kai Pinkernell

Chief Medical Officer (CMO) & Chief Development Officer

Medigene

Nuno Pinto, PhD

Senior Scientist

Merck & Co., Inc.

David Quach

Instructor

Center for Cell and Gene Therapy, Baylor College of Medicine, USA

Lior Raviv

Vice President

Pluristem Therapeutics Inc.

Andrew Rigoglioso

Associate Director, Talent Acquisition

Flagship Pioneering

Donna Rill

Chief Development Officer

Opexa Therapeutics, USA

Nadine M. Ritter, Ph.D.

President and Analytical Advisor

Global Biotech Experts, LLC

Jon A. Rowley, Ph.D.

Chief Executive & Technology Officer

RoosterBio Inc.

Jennifer Royal-Fitch

Talent Acquisition Leader

Gene Therapy Program & The Orphan Disease Center, Univeristy of Pennsylvania

Gregory Russotti

Chief Technology Officer

Century Therapeutics LLC, USA

Dominic Schmidt

Partner

Syncona Investment Management Ltd., UK

Franz Schnetzinger

Director Analytical Development

Gyroscrope, UK

Joe Sexton

Senior Technical Specialist

Genentech

Hana Sheikh

MSAT Engineer II

Genentech

Lara Ionescu Silverman

Senior Director, Research and Development

DiscGenics

Andrew Sinclair

Managing Director

Biopharm Services

Donald Singer

GSK Senior Fellow, Microbiology, Biopharmaceutical GMP Operations

GSK, USA

Anupam Singhal, PhD

Product Manager, Antibody Therapeutics

Berkeley Lights, Inc.

Michael Sokolov

COO

DataHow

James Trager

Chief Scientific Officer

Nkarta Therapeutics, USA

Nobel Vale

Research Scientist II

Bristol-Myers Squibb

Steven Walfish

Principal Science & Standards Liaison

United States Pharmacopeia (USP)

Kathy Williams

VP of Quality and Reg Affairs

RoosterBio, Inc., USA

Leslie Wolfe, PhD

Director, Downstream Process Development

KBI Biopharma

Yang Wu

Scientist II

Macrogenics

Bruce Yu

Professor

Maryland University

Carlo Zambonelli

Associate Director of Analytical Development

Beam Therapeutics Inc., USA

Frank Zhang

Vice President, Head of Market Access & Policy

uniQure

Mike Zhao

Senior Vice President

MSQ Ventures

George Zhou, PhD

Associate Principal Scientist

Merck & Co., Inc.

Andrew L. Zydney, Ph.D.

Bayard D. Kunkle Chair and Professor of Chemical Engineering

The Pennsylvania State University